Global Corneal Ulcer Treatment Market, By Treatment (Medication, Surgery, Others), Diagnosis (Fluorescein Eye Stain Test, Slit-Lamp Exam, Others), Symptoms (Redness, Tears, Discharge from Eye, Blurry Vision, Swollen Eyelids, Vision Changes, Severe Pain, Others), Dosage (Eye Drops, Tablets, Others), Route of Administration (Oral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, the market for corneal ulcer treatment is estimated to grow rapidly. The use of traditional drugs to treat corneal ulcers frequently results in corneal scarring and blurred vision. Manufacturers have responded by developing unique and alternative drugs, such as dual therapy (drug combinations), which are anticipated to fuel the corneal ulcer treatment market's expansion.
- An open sore on your cornea, the thin clear layer that covers your iris, is known as a corneal ulcer. Keratitis is another name for it. The treatment for corneal ulcers and infections is determined on the underlying cause. To avoid corneal scarring, treatment should begin as soon as feasible. Antibiotics, as well as antiviral and antifungal drugs, are commonly used in treatment.
- Data Bridge Market Research analyses that the corneal ulcer treatment market will grow at a CAGR of 6.50% during the forecast period of 2022 to 2029.
Corneal Ulcer Treatment Market Dynamics
Drivers
-
High prevalence rate of eye diseases
The rising prevalence rate eye diseases globally will act as a major driver and result in the expansion of the growth rate of the market.
-
Growing use of contact lenses
Another significant factor influencing the growth rate of corneal ulcer treatment market is the rising utilization of contact lenses and chemical exposure causing ulcers.
Furthermore, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the corneal ulcer treatment market. Other factors such as increase in healthcare expenditure and advancement of medical technology will positively impact the corneal ulcer treatment market's growth rate. Additionally, high disposable income along with changing lifestyle will result in the expansion of corneal ulcer treatment market. Surging number of geriatric population will be a contributing factor enhancing the pulpitis risk and increasing the treatment market’s demand.
Opportunities
-
Rise in the investment for R&D by public and private organizations
Moreover, the rise in the research and development activities and favourable reimbursement policies in developed regions will boost new opportunities for the market's growth rate.
Also, well-established supply chain of generic manufacturers and developments in healthcare technology will provide beneficial opportunities for the corneal ulcer treatment market in the forecast period of 2022-2029.
Restraints/Challenges
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of corneal ulcer treatment market. Additionally, complications involved with the diseases will hinder the corneal ulcer treatment market growth. Emergence of unfavourable conditions due to COVID-19 outbreak and less awareness in patients will further challenge the market in the forecast period mentioned above.
This corneal ulcer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on corneal ulcer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Corneal ulcer treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Corneal Ulcer Treatment Market
The COVID-19 pandemic's rapid spread has had a substantial influence on ocular procedures all around the world. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of corneal ulcer treatment in recent months. Ophthalmic surgeries are considered elective procedures, and the suspension of elective procedures during the pandemic lowered the number of people receiving ophthalmic surgery worldwide.
Global Corneal Ulcer Treatment Market Scope
The corneal ulcer treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Medication
- Surgery
- Others
On the basis of treatment, the corneal ulcer treatment market is segmented into medication, surgery, and others. Medication segment is further segmented into antibiotics, antiviral, antifungal, corticosteroids, antiamoebic, non-steroidal anti-inflammatory drugs (NSAIDs) and others.
Diagnosis
- Fluorescein Eye Stain Test
- Slit-Lamp Exam
- Others
On the basis of diagnosis, the corneal ulcer treatment market is segmented into fluorescein eye stain test, slit-lamp exam and others.
Symptoms
- Redness
- Tears
- Discharge from Eye
- Blurry Vision
- Swollen Eyelids
- Vision Changes
- Severe Pain
- Others
On the basis of symptoms, the corneal ulcer treatment market is segmented into redness, tears, discharge from eye, blurry vision, swollen eyelids, vision changes, severe pain and others.
Dosage
- Eye Drops
- Tablet
- Others
On the basis of dosage, the corneal ulcer treatment market is segmented into eye drops, tablet and others.
Route of Administration
- Oral
- Topical
- Others
On the basis of route of administration, the corneal ulcer treatment market is segmented into oral, topical and others.
End-Users
- Clinic
- Hospital
- Others
On the basis of end-users, the corneal ulcer treatment market is segmented into clinic, hospital and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The corneal ulcer treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Corneal Ulcer Treatment Market Regional Analysis/Insights
The corneal ulcer treatment market is analysed and market size insights and trends are provided by country, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the corneal ulcer treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the corneal ulcer treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Corneal Ulcer Treatment Market Share Analysis
The corneal ulcer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to corneal ulcer treatment market.
Some of the major players operating in the corneal ulcer treatment market are Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Allergan, Merck & Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics LLC, Eli Lilly and Company, Cipla Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca, and Johnson & Johnson Private Limited, among others.
SKU-